List of drugs: Re Human Genome Sciences Growth factor receptor inhibitor Keratinocyte growth factor Neurotrophic factor receptor Fibroblast growth factor GDNF family of ligands Growth factor receptor Ephrin Ramucirumab Tyrosine kinase inhibitor Ciliary neurotrophic factor receptor FGF16 Robatumumab Mirvetuximab soravtansine Duligotuzumab Rilotumumab Icrucumab Becaplermin FGF22 Palifermin Ancestim Matuzumab Trafermin Neurotrophin Figitumumab Flanvotumab Insulin-like growth factor-binding protein Dalotuzumab Neuregulin Onartuzumab Ertumaxomab IGF-1 LR3 Emibetuzumab Ficlatuzumab Teprotumumab FGF20 Imgatuzumab Mecasermin rinfabate Hemopoietic growth factor Faricimab FGF15 Fut…

tuximab Fulranumab Platelet-derived growth factor Alacizumab pegol Angiopoietin Nimotuzumab Necitumumab Pertuzumab/trastuzumab/hyaluronidase Amivantamab Adult neurogenesis Cetuximab Eutropoflavin Seribantumab Tovetumab Neurotrophic factors Trastuzumab/hyaluronidase FGF15/19 Cerebrolysin Dusigitumab Vascular endothelial growth factor Dihexa Cenegermin BNN-20 Trk receptor Evinacumab R13 (drug) Norwogonin FGF11 Anti-VEGF Patritumab Pertuzumab Des(1-3)IGF-1 HIOC Motesanib Semaxanib Bevacizumab LM22A-4 Brolucizum

ab ANA-12 Trofinetide IGFBP7 Fruquintinib RTK class III Glia maturation factor 7,8,3'-Trihydroxyflavone Grandinin Mecasermin Repotrectinib Radotinib Cediranib Neuregulin 4 Tavilermide Trametinib Avapritinib Trastuzumab Ephrin receptor Ceritinib Olaratumab Panitumumab R7 (drug) Ranibizumab Tyrosine kinase Pralsetinib Olmutinib Receptor activity-modifying protein Linsitinib Renalase Selpercatinib Nilotinib Asciminib Persephin Cixutumumab Nesvacumab Zalutumumab Ganitumab Fasinumab GFRα Neurturin Brigatinib Binimetinib Rociletinib IGFBP6 Growth factor Insulin-like growth factor Tucatinib Cabozantinib